3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment

Details for Australian Patent Application No. 2010333083 (hide)

Owner Johannes Gutenberg-Universitat Mainz

Inventors Dannhardt, Gerd; Kramb, Jan-Peter; Plutizki, Stanislav

Agent Freehills

Pub. Number AU-A-2010333083

PCT Pub. Number WO2011/073092

Priority 09179986.6 18.12.09 EP

Filing date 10 December 2010

Wipo publication date 23 June 2011

International Classifications

C07D 403/04 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/404

A61K 31/437

A61P 35/00 Antineoplastic agents

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/073092 Priority application(s): WO2011/073092

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010333099-Man/machine dialogue system

2010333082-3-(indolyl)-or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarzinoma